Synthorx Shares Up 165% After Sanofi Buyout Offer
December 09 2019 - 7:23AM
Dow Jones News
By Chris Wack
Synthorx Inc. (THOR) shares were up 165% to $66.28 premarket
after Sanofi SA (SAN.FR) said it was buying the clinical-stage
biotechnology for $68 a share in cash.
The deal has an equity value of about $2.5 billion, and is
expected to close in the first quarter of next year.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
December 09, 2019 07:08 ET (12:08 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Synthorx (NASDAQ:THOR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Synthorx (NASDAQ:THOR)
Historical Stock Chart
From Jul 2023 to Jul 2024